PepGen Inc. has received regulatory approval to launch its Freedom2 clinical trial program in South Korea, Australia, and New Zealand.
Show original
This development marks an important step for the company in expanding its global clinical development footprint, making it possible for patients in relevant regions to participate in innovative therapy research.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$72,647.24
+6.35%
Ethereum
ETH
$2,124.93
+7.13%
Tether USDt
USDT
$1
+0.01%
BNB
BNB
$657.71
+3.73%
XRP
XRP
$1.43
+5.08%
USDC
USDC
$0.9997
-0.02%
Solana
SOL
$90.93
+4.24%
TRON
TRX
$0.2871
+2.35%
Dogecoin
DOGE
$0.09913
+10.02%
Cardano
ADA
$0.2762
+4.96%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now